Safety and clinical activity of durvalumab monotherapy in patients with microsatellite instability high (MSI-H) tumors Meeting Abstract


Authors: Segal, N. H.; Wainberg, Z. A.; Overman, M. J.; Ascierto, P. A.; Arkenau, H. T.; Butler, M. O.; Eder, J. P.; Keilholz, U.; Kim, D. W.; Cunningham, D.; Khleif, S. N.; Doucet, L.; Lee, J. S.; Nemunaitis, J. J.; Vaishampayan, U. N.; Weiss, J.; Gao, C.; Abdullah, S. E.; Hollebecque, A.
Abstract Title: Safety and clinical activity of durvalumab monotherapy in patients with microsatellite instability high (MSI-H) tumors
Meeting Title: 2019 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 4 Suppl.
Meeting Dates: 2019 Jan 17-19
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000489107600672
DOI: 10.1200/JCO.2019.37.4_suppl.670
PROVIDER: wos
Notes: Meeting Abstract: 670 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neil Howard Segal
    209 Segal